{"ticker": {"uuid": "a48f382e-c110-468c-9c9b-b2fb91dd0dd3", "symbol": "ALT1", "name": "Altimmune, Inc.", "exchange": "MEX", "country": "MX", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswJBVV95cUxNUS1faUQySXRPVjBaem9QRGttdnYzaldac3lKVEU3bEtDNUVEV1I2LWxPd25pdEZmbG5USWxzX3lqV3dJYTVFVGt4R01WcEI1T3lYTVRuZkxza3M2TkZqUmoyM1czcHpwbWU2YjRBQ2NpVjBGMTJXMDhhUzJFUzZOc2lqSlE3THhlRjBpdEtPNk1wcDVrOGtHOF9DSVpKQU9oU215MVlWZFlHZDhUV2kxWGktUVptOGw4a2Jha3dNZUNkaWxOZlZndkJGQ0EyelBVNmxTREYwNjgtTE5fejRoWXRCcnBaeC1fVHB5TzRyRFpLTTQ0VWJ1dUhFYjBIT0tySTRjb0Z3TmVNM3RJcVhia3o3V01KX3ktTm5JWVZ1WGVtQkZ2MHR5dHN1OHBMTHdfVFpB?oc=5", "source_name": "PR Newswire", "published_at": "2025-09-08T07:00:00+00:00", "published_display": "08 Sep 2025 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswJBVV95cUxNUS1faUQySXRPVjBaem9QRGttdnYzaldac3lKVEU3bEtDNUVEV1I2LWxPd25pdEZmbG5USWxzX3lqV3dJYTVFVGt4R01WcEI1T3lYTVRuZkxza3M2TkZqUmoyM1czcHpwbWU2YjRBQ2NpVjBGMTJXMDhhUzJFUzZOc2lqSlE3THhlRjBpdEtPNk1wcDVrOGtHOF9DSVpKQU9oU215MVlWZFlHZDhUV2kxWGktUVptOGw4a2Jha3dNZUNkaWxOZlZndkJGQ0EyelBVNmxTREYwNjgtTE5fejRoWXRCcnBaeC1fVHB5TzRyRFpLTTQ0VWJ1dUhFYjBIT0tySTRjb0Z3TmVNM3RJcVhia3o3V01KX3ktTm5JWVZ1WGVtQkZ2MHR5dHN1OHBMTHdfVFpB?oc=5", "source_name": "PR Newswire", "published_at": "2025-09-08T07:00:00+00:00", "published_display": "08 Sep 2025 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 56, "total_relevant": 1, "sentiment_summary": {"positive": 0, "negative": 1, "neutral": 0, "score": 18, "total": 1, "label": "Cautious news tone", "tone": "negative"}, "classifier": {"primary_event": "regulatory", "primary_label": "Regulatory and legal", "confidence": 72, "events": [{"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 50.09, "latest_week": "2026-07-17", "one_week_move": -6.2, "four_week_move": 6.2, "twelve_week_move": 1.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.311414, "market_dynamics_buy_signal": false, "relative_strength": -31.341954, "fair_value_gap": -53.4, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 18.8869, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-6.2% over one week, +6.2% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Caution confirmed by price", "tone": "negative", "classification": "confirmed_negative", "summary": "Cautious news tone is being confirmed by negative weekly price action.", "confidence": 90, "badges": ["Caution agrees with inactive trend"], "opportunities": [], "risks": ["Negative tone is aligned with an inactive trend backdrop."], "event_label": "Regulatory and legal", "sentiment_word": "cautious"}, "charts": {"sources": [{"label": "PR Newswire", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 1}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "18/100", "tone": "negative", "text": "Cautious news tone"}, {"label": "Market reaction", "value": "Caution confirmed by price", "tone": "negative", "text": "Cautious news tone is being confirmed by negative weekly price action."}, {"label": "Primary event", "value": "Regulatory and legal", "tone": "negative", "text": "72/100 classification confidence."}, {"label": "Company focus", "value": "1", "tone": "neutral", "text": "directly relevant article"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-6.2% over one week, +6.2% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT"}], "updated_at": "2026-07-21T21:40:44.389211+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}